The tuberous sclerosis complex

PB Crino, KL Nathanson… - New England Journal of …, 2006 - Mass Medical Soc
The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder
affecting children and adults, results from mutations in one of two genes, TSC1 (encoding …

[HTML][HTML] Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

H Northrup, DA Krueger, S Roberds, K Smith… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is highly variable in clinical presentation and
findings. Disease manifestations continue to develop over the lifetime of an affected …

Metastasis of benign tumor cells in tuberous sclerosis complex

EP Henske - Genes, Chromosomes and Cancer, 2003 - Wiley Online Library
Lymphangiomyomatosis (LAM) is a life‐threatening lung disease affecting almost
exclusively young women. Histologically, LAM is characterized by the diffuse, bilateral …

[HTML][HTML] Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

DA Krueger, H Northrup, S Roberds, K Smith… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is a genetic disorder affecting every organ system,
but disease manifestations vary significantly among affected individuals. The diverse and …

Female sex and gender in lung/sleep health and disease. Increased understanding of basic biological, pathophysiological, and behavioral mechanisms leading to …

MLK Han, E Arteaga-Solis, J Blenis… - American journal of …, 2018 - atsjournals.org
Female sex/gender is an undercharacterized variable in studies related to lung development
and disease. Notwithstanding, many aspects of lung and sleep biology and pathobiology …

Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis

T Carsillo, A Astrinidis… - Proceedings of the …, 2000 - National Acad Sciences
Lymphangioleiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease
characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is …

Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.

EP Henske, BW Scheithauer, MP Short… - American journal of …, 1996 - ncbi.nlm.nih.gov
Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by seizures,
mental retardation, and hamartomatous lesions. Although hamartomas can occur in almost …

[PDF][PDF] Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from …

TA Smolarek, LL Wessner, FX McCormack… - The American Journal of …, 1998 - cell.com
Lymphangiomyomatosis (LAM) is a rare disease, of unknown etiology, affecting women
almost exclusively. Lung transplantation is the only consistently effective therapy for LAM …

Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism

M Karbowniczek, A Astrinidis, BR Balsara… - American journal of …, 2003 - atsjournals.org
Lymphangiomyomatosis (LAM) is characterized by the proliferation of abnormal smooth
muscle cells and cystic degeneration of the lung. LAM affects almost exclusively young …

Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis.

JL Brasier, EP Henske - The Journal of clinical investigation, 1997 - Am Soc Clin Investig
It is not known whether mutations in the PKD1 gene cause autosomal dominant polycystic
kidney disease (PKD) by an activating (gain-of-function) or an inactivating (loss-of-function) …